{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04665037",
            "orgStudyIdInfo": {
                "id": "5592-127"
            },
            "secondaryIdInfos": [
                {
                    "id": "MK-5592-127",
                    "type": "OTHER",
                    "domain": "Merck"
                },
                {
                    "id": "PHRR230411-005589",
                    "type": "REGISTRY",
                    "domain": "PHRR"
                },
                {
                    "id": "2023-505613-24",
                    "type": "REGISTRY",
                    "domain": "EU CT"
                },
                {
                    "id": "2019-003842-34",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)",
            "officialTitle": "A Phase 2, Open-Label, Single-Arm, Sequential-Panel Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Posaconazole (POS, MK-5592) Intravenous and Powder for Oral Suspension Formulations in Pediatric Participants From Birth to Less Than 2 Years of Age With Possible, Probable, or Proven Invasive Fungal Infection",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "posaconazole-mk-intravenous-and-oral-in-children-years-with-invasive-fungal-infection-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-02-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-16",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-12-09",
            "studyFirstSubmitQcDate": "2020-12-09",
            "studyFirstPostDateStruct": {
                "date": "2020-12-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pediatric participants \\<2 years of age with invasive fungal infection (IFI).",
            "detailedDescription": "There are 2 panels in this study. In Panel A, POS IV will be evaluated in \u22658 participants. In Panel B, both POS IV and POS PFS will be evaluated in \u226514 participants, including \u22656 who are \\<3 months of age and \u22655 who transition to the PFS formulation of POS."
        },
        "conditionsModule": {
            "conditions": [
                "Invasive Fungal Infection"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Panel A: POS IV",
                    "type": "EXPERIMENTAL",
                    "description": "Posaconazole 6 mg/kg body weight administered in a single dose by IV infusion on Day 1.",
                    "interventionNames": [
                        "Drug: Posaconazole IV 6 mg/kg"
                    ]
                },
                {
                    "label": "Panel B: POS IV",
                    "type": "EXPERIMENTAL",
                    "description": "Posaconazole 6 mg/kg body weight administered twice daily by IV infusion on Day 1, and then once daily from Day 2 to a maximum 84 days.",
                    "interventionNames": [
                        "Drug: Posaconazole IV 6 mg/kg"
                    ]
                },
                {
                    "label": "Panel B: POS PFS",
                    "type": "EXPERIMENTAL",
                    "description": "Following a minimum of 7 days IV dosing, participants as clinically able will be transitioned from POS IV to POS PFS nominal 6 mg/kg body weight based on weight bands administered on Day 8, once daily to a maximum 84 days.",
                    "interventionNames": [
                        "Drug: Posaconazole PFS 6 mg/kg"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Posaconazole IV 6 mg/kg",
                    "description": "POS 6 mg/kg body weight by IV infusion",
                    "armGroupLabels": [
                        "Panel A: POS IV",
                        "Panel B: POS IV"
                    ],
                    "otherNames": [
                        "MK-5592",
                        "NOXAFIL\u00ae",
                        "SCH56592"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Posaconazole PFS 6 mg/kg",
                    "description": "POS nominal 6 mg/kg body weight based on weight bands taken orally",
                    "armGroupLabels": [
                        "Panel B: POS PFS"
                    ],
                    "otherNames": [
                        "MK-5592",
                        "NOXAFIL\u00ae",
                        "SCH56592"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Average concentration (Cavg) of single-dose IV POS (Panel A)",
                    "description": "The Cavg of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose, 0.25 and 24 hours post-infusion on Day 1"
                },
                {
                    "measure": "Maximum concentration (Cmax) of single-dose IV POS (Panel A)",
                    "description": "The Cmax of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose, 0.25 and 24 hours post-infusion on Day 1"
                },
                {
                    "measure": "Time to maximum concentration (Tmax) of single-dose IV POS (Panel A)",
                    "description": "The Tmax of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose, 0.25 and 24 hours post-infusion on Day 1"
                },
                {
                    "measure": "Area under the plasma concentration-time curve from dosing to 24 hours postdose (AUC0-24) of single-dose IV POS (Panel A)",
                    "description": "The AUC 0-24 of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose, 0.25 and 24 hours post-infusion on Day 1"
                },
                {
                    "measure": "Clearance (CL) of single-dose IV POS (Panel A)",
                    "description": "The clearance (CL) of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose, 0.25 and 24 hours post-infusion on Day 1"
                },
                {
                    "measure": "Area under the plasma concentration-time curve from dosing to infinity (AUC0-\u221e) of single-dose IV POS (Panel A)",
                    "description": "The AUC0-\u221e of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose, 0.25 and 24 hours post-infusion on Day 1"
                },
                {
                    "measure": "Cavg of multiple-dose IV POS (Panel B)",
                    "description": "The Cavg of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "Cmax of multiple-dose IV POS (Panel B)",
                    "description": "The Cmax of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "Tmax of multiple-dose IV POS (Panel B)",
                    "description": "The Tmax of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "AUC0-24 of multiple-dose IV POS (Panel B)",
                    "description": "The AUC0-24 of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "CL of multiple-dose IV POS (Panel B)",
                    "description": "The CL of IV POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "Cavg of multiple-dose PFS POS (Panel B)",
                    "description": "The Cavg of PFS POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "Cmax of multiple-dose PFS POS (Panel B)",
                    "description": "The Cmax of PFS POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "AUC0-24 of multiple-dose PFSPOS (Panel B)",
                    "description": "The AUC0-24 of PFS POS is based on population PK analysis.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Cavg of IV POS in neonates and infants <2 years of age compared to adults and older pediatric populations (Panel B)",
                    "description": "The Cavg of IV POS is based on population PK analysis. Comparisons between participants in Panel B will be made to data that was previously collected in older participants.",
                    "timeFrame": "Predose and 0.25 post-infusion on Day 1; Weeks 1, 2, 4, 6, 9, and 12"
                },
                {
                    "measure": "Percentage of participants with an \u2265 1 adverse event (AE) [Panels A and B]",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to 98 days"
                },
                {
                    "measure": "Percentage of participants who discontinued study therapy due to an AE (Panels A and B)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to 84 days"
                },
                {
                    "measure": "Percentage of participants with a drug-related AE (Panels A and B)",
                    "description": "An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention.",
                    "timeFrame": "Up to 98 days"
                },
                {
                    "measure": "Percentage of participants with all-cause mortality (ACM) [Panel B]",
                    "description": "The percentage of participants with ACM will be reported.",
                    "timeFrame": "Up to 28 days"
                },
                {
                    "measure": "Percentage of participants with need for systemic antifungal therapy (other than POS) during the study period (Panel B)",
                    "description": "Percentage of participants who received additional antifungal therapy in Panel B will be reported.",
                    "timeFrame": "Up to 84 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Panel A: is undergoing treatment for possible, probable, or proven IFI known or suspected to be cause by fungal pathogens against which POS has demonstrated activity (which can include candidiasis)\n* Panel B: has an investigator-assessed diagnosis of possible, probable, or proven IFI known or suspected to be cause by fungal pathogens against which POS has demonstrated activity (and cannot include candidiasis)\n* Has a central line (eg, central venous catheter, peripherally-inserted central catheter) in place or planned to be in place before beginning IV study intervention.\n* Has a body weight of \u2265500 g\n* The participant (or legally acceptable representative) has provided documented informed consent for the study.\n\nExclusion Criteria\n\n* Has received POS within 30 days before Day 1\n* Has cystic fibrosis, pulmonary sarcoidosis, aspergilloma, or allergic bronchopulmonary aspergillosis\n* Has a known hereditary problem of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption\n* Has known or suspected active COVID-19 infection\n* Has a known hypersensitivity or other serious adverse reaction to any azole antifungal therapy, or to any other ingredient of the study intervention used\n* Has any known history of torsade de pointes, unstable cardiac arrhythmia or proarrhythmic conditions, a history of recent myocardial infarction, congenital or acquired QT interval (QT) prolongation, or cardiomyopathy in the context of cardiac failure within 90 days of first dose of study intervention\n* Has received any listed prohibited medications within the specified timeframes before the start of study intervention\n* Has a known hereditary problem of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption (Part B)\n* Has suspected/proven invasive candidiasis (Part B)\n* Has enrolled previously in the current study and been discontinued\n* Has QTc prolongation at screening \\>500 msec\n* Has significant liver dysfunction\n* Is hemodynamically unstable, exhibits hemodynamic compromise, or is not expected to survive at least 5 days",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Day",
            "maximumAge": "2 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Rady Children's Hospital-San Diego ( Site 2101)",
                    "status": "COMPLETED",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92123",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Nicklaus Children's Hospital ( Site 2109)",
                    "status": "COMPLETED",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33155",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 2104)",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "312-227-6280"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Duke University Medical Center ( Site 2106)",
                    "status": "COMPLETED",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Driscoll Children's Hospital ( Site 2113)",
                    "status": "COMPLETED",
                    "city": "Corpus Christi",
                    "state": "Texas",
                    "zip": "78411",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.80058,
                        "lon": -97.39638
                    }
                },
                {
                    "facility": "UCL Saint Luc ( Site 1050)",
                    "status": "RECRUITING",
                    "city": "Brussels",
                    "state": "Bruxelles-Capitale, Region De",
                    "zip": "1200",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3227646086"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.85045,
                        "lon": 4.34878
                    }
                },
                {
                    "facility": "UZ Gent ( Site 1052)",
                    "status": "RECRUITING",
                    "city": "Gent",
                    "state": "Oost-Vlaanderen",
                    "zip": "9000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3293324986"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "UZ Leuven ( Site 1051)",
                    "status": "RECRUITING",
                    "city": "Leuven",
                    "state": "Vlaams-Brabant",
                    "zip": "3000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3216343972"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "Athens Childrens Hospital Aglaia Kyriakou ( Site 1102)",
                    "status": "RECRUITING",
                    "city": "Athens",
                    "state": "Attiki",
                    "zip": "115 27",
                    "country": "Greece",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+306973973179"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.97945,
                        "lon": 23.71622
                    }
                },
                {
                    "facility": "General Hospital of Thessaloniki \"Ippokrateio\" ( Site 1100)",
                    "status": "RECRUITING",
                    "city": "Thessaloniki",
                    "zip": "546 42",
                    "country": "Greece",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "306937442644"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.64361,
                        "lon": 22.93086
                    }
                },
                {
                    "facility": "Rambam Medical Center ( Site 1402)",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "3109601",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97247774512"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah Ein Karem Hebrew University Medical Center ( Site 1401)",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "9112001",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97226777111"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Sheba Medical Center ( Site 1404)",
                    "status": "RECRUITING",
                    "city": "Ramat Gan",
                    "zip": "5265601",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+9720544903022"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08227,
                        "lon": 34.81065
                    }
                },
                {
                    "facility": "Sourasky Medical Center ( Site 1403)",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97236974521"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Instituto Nacional de Pediatria-Unidad de Apoyo a la Investigaci\u00f3n Cl\u00ednica ( Site 2200)",
                    "status": "RECRUITING",
                    "city": "Mexico City",
                    "state": "Distrito Federal",
                    "zip": "04530",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "5525600809"
                        }
                    ],
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Hospital Infantil de Mexico Federico Gomez-Infectious Diseases ( Site 2202)",
                    "status": "RECRUITING",
                    "city": "Mexico City",
                    "state": "Distrito Federal",
                    "zip": "06720",
                    "country": "Mexico",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "525539391946"
                        }
                    ],
                    "geoPoint": {
                        "lat": 19.42847,
                        "lon": -99.12766
                    }
                },
                {
                    "facility": "Instituto Nacional de Enfermedades Neoplasicas ( Site 1601)",
                    "status": "RECRUITING",
                    "city": "Lima",
                    "zip": "15038",
                    "country": "Peru",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+5112016500"
                        }
                    ],
                    "geoPoint": {
                        "lat": -12.04318,
                        "lon": -77.02824
                    }
                },
                {
                    "facility": "Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckieg-Klinika Transplantacji Szpiku, Onkolog",
                    "status": "RECRUITING",
                    "city": "Wroc\u0142aw",
                    "state": "Dolnoslaskie",
                    "zip": "50-556",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "48717332840"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.1,
                        "lon": 17.03333
                    }
                },
                {
                    "facility": "Wojewodzki Specjalistyczny Szpital Dzieciecy ( Site 1705)",
                    "status": "RECRUITING",
                    "city": "Olsztyn",
                    "state": "Warminsko-mazurskie",
                    "zip": "10-561",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "0048895393370"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.77995,
                        "lon": 20.49416
                    }
                },
                {
                    "facility": "Mechnikov State Medical University ( Site 1803)",
                    "status": "COMPLETED",
                    "city": "Saint Petersburg",
                    "state": "Sankt-Peterburg",
                    "zip": "194291",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Pavlov State Medical University ( Site 1801)",
                    "status": "COMPLETED",
                    "city": "Saint Petersburg",
                    "state": "Sankt-Peterburg",
                    "zip": "197022",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 59.93863,
                        "lon": 30.31413
                    }
                },
                {
                    "facility": "Regional Children Clinical Hospital 1 ( Site 1802)",
                    "status": "COMPLETED",
                    "city": "Ekaterinburg",
                    "state": "Sverdlovskaya Oblast",
                    "zip": "620149",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 56.8519,
                        "lon": 60.6122
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "https://www.merckclinicaltrials.com/"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=5592-127&&kw=5592-127"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000009181",
                    "term": "Mycoses"
                },
                {
                    "id": "D000072742",
                    "term": "Invasive Fungal Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000001423",
                    "term": "Bacterial Infections and Mycoses"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12136",
                    "name": "Mycoses",
                    "asFound": "Fungal Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1099",
                    "name": "Invasive Fungal Infections",
                    "asFound": "Invasive Fungal Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M4722",
                    "name": "Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M4721",
                    "name": "Bacterial Infections and Mycoses",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000101425",
                    "term": "Posaconazole"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000935",
                    "term": "Antifungal Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000014344",
                    "term": "Trypanocidal Agents"
                },
                {
                    "id": "D000000981",
                    "term": "Antiprotozoal Agents"
                },
                {
                    "id": "D000000977",
                    "term": "Antiparasitic Agents"
                },
                {
                    "id": "D000058888",
                    "term": "14-alpha Demethylase Inhibitors"
                },
                {
                    "id": "D000065607",
                    "term": "Cytochrome P-450 Enzyme Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000065088",
                    "term": "Steroid Synthesis Inhibitors"
                },
                {
                    "id": "D000006727",
                    "term": "Hormone Antagonists"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M219015",
                    "name": "Posaconazole",
                    "asFound": "Sphincter",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6252",
                    "name": "Clotrimazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M11796",
                    "name": "Miconazole",
                    "relevance": "LOW"
                },
                {
                    "id": "M4254",
                    "name": "Antifungal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4298",
                    "name": "Antiprotozoal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4294",
                    "name": "Antiparasitic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M30537",
                    "name": "Cytochrome P-450 Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}